Local hypoxia (HX) has been identified as an anti‐inflammatory mediator through induction of HIF‐ dependent genes. Microarray analysis of HMECs exposed to HX identified ADM as a prominent HX‐inducible gene. ADM has been shown to diminish the severity of inflammation in a number of models. We sought to determine the molecular pathways which converge to confer an anti‐inflammatory phenotype. rhADM treatment resulted in a de‐neddylation of Cullin family members, reported to control NF¿B & HIF activity, respectively. NF¿B & HRE luciferase reporter assays confirmed suppression of NF¿B & activation of HRE by ADM. To address ADM signaling on HIF‐1 activation, we identified an increase in canonical HIF‐1 dependent genes following stimulation with ADM. As an in vivo model, we investigated the role of ADM in treating a DSS model of colitis. Mice treated with ADM had reduced inflammatory indices compared with sham‐ treated DSS mice, which lost more weight & had significant shortening of the colon compared with healthy controls. Furthermore, histological analysis identified less inflammation in ADM treated mice compared to sham‐treated. Whole colon & serum cytokine analysis showed a marked inhibition of DSS colitis‐associated TNF‐α, IL‐1β & KC. Together, these results demonstrate that ADM may act as an administrable therapy to reduce the severity of inflammation through the central action on Cullin family members.
Read full abstract